ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 975

Dense Genotyping of Risk Loci in Black South Africans with Rheumatoid Arthritis: An Association Study

Nimmisha Govind1, Ananyo Choudhury2, Bridget Hodkinson1, Claudia Ickinger1, Jacqueline Frost3, Annette T. Lee4, Peter K. Gregersen5, Richard J. Reynolds6, S. Louis Bridges Jr.7, Scott Hazelhurst2, Michèle Ramsay3 and Mohammed Tikly1, 1Rheumatology, Division of Rheumatology, University of the Witwatersrand, Johannesburg, South Africa, 2Wits Bioinformatics Department, Wits Bioinformatics Department, University of the Witwatersrand, Johannesburg, South Africa, 3Division of Human Genetics, National Health Laboratory Service, Division of Human Genetics, National Health Laboratory Service, University of the Witwatersrand, Johannesburg, South Africa, 4Genomics & Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 5Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 6Clinical Immunology and Rheumatology, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 7University of Alabama at Birmingham, Birmingham, AL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Genome wide association studies (GWAS) have identified numerous rheumatoid arthritis (RA) risk loci in patients of European and Asian ancestry but the causal variants have rarely been identified. These studies have also identified susceptibility loci that are common to various autoimmune diseases. The need to identify casual variants prompted the design of the Immunochip, a custom Illumina Infinium high density genotyping array, with ~196 000 single nucleotide polymorphisms (SNPs) from 186 loci previously associated with 12 autoimmune diseases. Little is known about the genetics of RA in black South Africans. We aimed to test associations with known genetic loci and to identify novel risk loci in black South Africans with RA.

Methods:

Consenting black RA patients fulfilling the 1987 ACR criteria for RA, >18 years at disease onset, and seen at a single centre in Johannesburg, South Africa were studied and compared to ethnically and geographically matched controls. Genotyping of 716 samples was performed using the Immunochip. Only samples with ≥94% call rate and individual SNPs with ≥95% call rate, were polymorphic, in Hardy-Weinberg equilibrium (p≥5×10-7) and with a minor allele frequency of ≥0.02 were analyzed. The cohort was further pruned for relatedness and ancestral outliers. After quality control, 117 353 SNPs were tested for association in 263 cases and 365 controls. The statistical analysis was performed using PLINK vers1.07. A p value = <5x10-8 was considered significant based on previous genome wide association studies.

Results:

The strongest associations were found in the MHC region with 64 SNPs reaching statistical significance. The most significant associations were in the intergenic region of the HLA DRB1- HLA DQA1 alleles (rs3104413, OR=3.88, p=5.49×10-21; rs3129769, OR=3.91, p=4.60×10-21; rs6931277, OR=3.97, p=1.03×10-21). There were 2 non HLA SNPs that reached genome wide significance, rs9283487 (OR=3.25, p=7.96 x10-18) in the PRKRA gene, and rs35198051 (OR=0.34, p=2.94×10-8) in the intergenic region of C11orf76 and LOC100133306. In addition there were suggestive associations of 2 SNPs on chromosome 1, rs12739262 (OR=0.36, p=1.36×10-7) in the PPP1R12B gene and rs12738883 (OR=0.36, p=1.69×10-7) in the intergenic region of PLD5 and LOC400723, both SNPs reached statistical significance in the rheumatoid factor (RF) positive subgroup (n=240/254) (rs12739262, OR=0.33, p=9.10×10-8 and rs12738883, OR= 0.33, p=9.10×10-8).

Conclusion:

In keeping with previous studies the HLA class II region confers the strongest genetic risk for RA in black South Africans. We also found 2 novel SNPs in the overall cohort and a further 2 SNPs in the RF positive subgroup. The association of the PRKRA gene with RA is of interest because of its recent association with Sjogren’s Syndrome. Further studies in larger cohorts of African patients are required to validate these findings and to better understand the functional role of these novel loci in the pathogenesis of RA in black South Africans.


Disclosure:

N. Govind,
None;

A. Choudhury,
None;

B. Hodkinson,
None;

C. Ickinger,
None;

J. Frost,
None;

A. T. Lee,
None;

P. K. Gregersen,
None;

R. J. Reynolds,
None;

S. L. Bridges Jr.,
None;

S. Hazelhurst,
None;

M. Ramsay,
None;

M. Tikly,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dense-genotyping-of-risk-loci-in-black-south-africans-with-rheumatoid-arthritis-an-association-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology